Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis.

MLA

Samson, Maxime, et al. “Human Monocyte-Derived Suppressive Cells (HuMoSC) for Cell Therapy in Giant Cell Arteritis.” Frontiers in Immunology, vol. 14, Feb. 2023, p. 1137794. EBSCOhost, https://doi.org/10.3389/fimmu.2023.1137794.

APA

Samson, M., Genet, C., Corbera-Bellalta, M., Greigert, H., Espígol-Frigolé, G., Gérard, C., Cladière, C., Alba-Rovira, R., Ciudad, M., Gabrielle, P.-H., Creuzot-Garcher, C., Tarris, G., Martin, L., Saas, P., Audia, S., Bonnotte, B., & Cid, M. C. (2023). Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritis. Frontiers in Immunology, 14, 1137794. https://doi.org/10.3389/fimmu.2023.1137794

Chicago

Samson, Maxime, Coraline Genet, Marc Corbera-Bellalta, Hélène Greigert, Georgina Espígol-Frigolé, Claire Gérard, Claudie Cladière, et al. 2023. “Human Monocyte-Derived Suppressive Cells (HuMoSC) for Cell Therapy in Giant Cell Arteritis.” Frontiers in Immunology 14 (February): 1137794. doi:10.3389/fimmu.2023.1137794.